当前位置： SCI文献检索 > Human Vaccines & Immunotherapeutics期刊下所有文献 > The regulatory T cells in anti-influenza antibody response post influenza vaccination.

The regulatory T cells in anti-influenza antibody response post influenza vaccination.

Abstract：

:The efficacy and effectiveness of influenza vaccines depend primarily on the vaccine recipient and the virus similarity to the endemic virus. Regulatory T cells (Tregs) and cytokines are known to restrict immune responses against viral infections. We conducted this study to explore the role of Tregs, cytokines, and antibody production after influenza vaccination. The whole blood was collected from healthy subjects (n = 36) before and two weeks after influenza vaccine immunization for two or three consecutive years. The cell surface markers, intracellular staining of Foxp3(+) Tregs, and Th1/Th2 cytokines were determined. The antibody titer was detected using the hemagglutination inhibition test. The CD3(+), CD127(+), CD4(+)CD25(+) and CD4(+)Foxp3(+) cells were increased significantly post vaccination. The plasma level of the transforming growth factor (TGF-β), but not interleukin (IL)-2, IL-4, IL-5, IL-10, IFN-γ, TNF-α, was also found to increase significantly after vaccination. We further correlated the cytokine fold-increases with the anti-influenza antibody titer for individual post vaccination. It was found that the IL-10 level after vaccination correlated with the fold-increases of anti-H1N1, anti-H3N2, anti-B/Yamagata, and anti-B/Victoria antibodies. But, a negative relationship occurs between the TGF-β level and fold-increases of anti-H1N1, anti-H3N2, anti-B/Yamagata, and anti-B/Victoria antibodies post vaccination. Treg cells and TGF-β seem to participate in the downregulation of the anti-influenza antibody response post influenza vaccination. Alteration of Treg activity might enhance influenza vaccine antibody responses and efficacy.

journal_name

Hum Vaccin Immunother

journal_title

Human vaccines & immunotherapeutics

authors

Wang SM,Tsai MH,Lei HY,Wang JR,Liu CC

doi

10.4161/hv.21117

subject

Has Abstract

pub_date

2012-09-01 00:00:00

pages

1243-9

issue

9

eissn

2164-5515

issn

2164-554X

pii

21117

journal_volume

8

pub_type

临床试验,杂志文章

相关文献

Human Vaccines & Immunotherapeutics文献大全
  • A physician's guide to the 2-dose schedule of MenB-FHbp vaccine.

    abstract：:Meningococcal serogroup B (MenB) is the predominant cause of invasive meningococcal disease in the United States, with older adolescents and young adults attending college at increased risk. Notably, MenB caused all meningococcal disease outbreaks at US colleges between 2011 and 2018. MenB disease is vaccine-preventab...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2019.1596711

    authors： McDaniel A,Dempsey A,Srivastava A

    更新日期：2019-01-01 00:00:00

  • The development of a recombinant hepatitis E vaccine HEV 239.

    abstract：:Hepatitis E virus (HEV) infection is one of the main causes of acute hepatitis worldwide. A recombinant hepatitis E vaccine, HEV 239, has been licensed in China for immunizing adults of 16 y old and above. The vaccine antigen contains pORF2 aa 368 - 606 of the HEV genotype 1 expressed in E. coli. The quality of the va...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2015.1008870

    authors： Li SW,Zhao Q,Wu T,Chen S,Zhang J,Xia NS

    更新日期：2015-01-01 00:00:00

  • Public awareness regarding children vaccination in Jordan.

    abstract：:Immunization can contribute to a dramatic reduction in number of vaccine-preventable diseases among children. The aim of this study is to investigate mothers' awareness about child vaccines and vaccination in Jordan. This study was a community-based, cross-sectional study that was performed at public places in Irbid C...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.28608

    authors： Masadeh MM,Alzoubi KH,Al-Azzam SI,Al-Agedi HS,Abu Rashid BE,Mukattash TL

    更新日期：2014-01-01 00:00:00

  • The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind,

    abstract：:We aimed to determine the efficacy of the 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in children aged 18-months to <18-years with recurrent protracted bacterial bronchitis (rPBB), chronic suppurative lung disease (CSLD) or bronchiectasis. In a multi-centre, double-blind randomi...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1488562

    authors： O'Grady KF,Chang AB,Cripps A,Mulholland EK,Smith-Vaughan H,Wood N,Danchin M,Thornton R,Wilson A,Torzillo PJ,Morris PM,Richmond P,Rablin S,Arnold D,Connor A,Goyal V,Stoney T,Perrett K,Grimwood K

    更新日期：2018-01-01 00:00:00

  • A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009-2016).

    abstract：:Higher-valent pneumococcal conjugate vaccines (PCVs) were licensed from 2009 in Europe; similar worldwide clinical effectiveness was observed for PCVs in routine use. Despite a proven medical need, PCV vaccination in Southern Europe remained suboptimal until 2015/16. We searched PubMed for manuscripts published betwee...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1263409

    authors： Moreira M,Castro O,Palmieri M,Efklidou S,Castagna S,Hoet B

    更新日期：2017-06-03 00:00:00

  • Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

    abstract：:Varicella zoster virus (VZV) is primarily known for causing varicella in childhood, but can reactivate again as herpes zoster (HZ) after a period of latency, mainly in persons older than 50 years. Universal varicella vaccination was introduced in Germany in 2004, while HZ vaccination has not been recommended yet. We a...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1135279

    authors： Horn J,Karch A,Damm O,Kretzschmar ME,Siedler A,Ultsch B,Weidemann F,Wichmann O,Hengel H,Greiner W,Mikolajczyk RT

    更新日期：2016-07-02 00:00:00

  • Economic evaluation of Varicella vaccination: results of a systematic review.

    abstract：INTRODUCTION:The aim of the present study is to review the economic burden of varicella disease and the benefit of universal varicella vaccination in different settings pending its implementation in all Italian regions. MATERIALS AND METHODS:Research was conducted using PubMed, Scopus and ISI databases. Score quality ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.25228

    authors： Unim B,Saulle R,Boccalini S,Taddei C,Ceccherini V,Boccia A,Bonanni P,La Torre G

    更新日期：2013-09-01 00:00:00

  • The use of technology to promote vaccination: A social ecological model based framework.

    abstract：:Vaccinations are an important and effective cornerstone of preventive medical care. Growing technologic capabilities and use by both patients and providers present critical opportunities to leverage these tools to improve vaccination rates and public health. We propose the Social Ecological Model as a useful theoretic...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2018.1477458

    authors： Kolff CA,Scott VP,Stockwell MS

    更新日期：2018-07-03 00:00:00

  • Parental vaccine attitudes, beliefs, and practices: initial evidence in California after a vaccine policy change.

    abstract：:Senate Bill 277 (SB277) eliminated nonmedical exemptions for school-entry vaccines in California, but the impact of parental vaccine knowledge, attitudes, and beliefs on vaccine decision-making has not been extensively examined within the post-SB277 context. This study generates preliminary understanding and discussio...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1839293

    authors： Holroyd TA,Howa AC,Delamater PL,Klein NP,Buttenheim AM,Limaye RJ,Proveaux TM,Omer SB,Salmon DA

    更新日期：2020-11-24 00:00:00

  • Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with men.

    abstract：:Human papillomavirus (HPV) vaccine programmes targeted at men who have sex with men (MSM) may reduce HPV-related disease burden among this at-risk group in countries where uptake of the vaccine among adolescent girls is sub-optimal and where adolescent boys are not routinely vaccinated. There are challenges to optimis...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1560783

    authors： Forster AS,Gilson R

    更新日期：2019-01-01 00:00:00

  • The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

    abstract：:Rapid production of influenza vaccine antigen is an important challenge when a new pandemic occurs. Production of recombinant antigens in plants is a quick, cost effective and up scalable new strategy for influenza vaccine production. In this study, we have characterized a recombinant influenza haemagglutinin antigen ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 临床试验,杂志文章

    doi：10.4161/hv.19503

    authors： Jul-Larsen Å,Madhun AS,Brokstad KA,Montomoli E,Yusibov V,Cox RJ

    更新日期：2012-05-01 00:00:00

  • Overview of the cancer vaccine field: are we moving forward?

    abstract：:Cancer immunotherapy has seen a tremendous number of failures and only few recent regulatory successes. This review is a first in a series dedicated to evaluate the status of current global clinical pipeline for cancer vaccines. Apart from specific areas of medical need which can be addressed by cancer vaccines, the a...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.20474

    authors： Kudrin A,Hanna MG Jr

    更新日期：2012-08-01 00:00:00

  • A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

    abstract：:The licensed meningococcal serogroup B vaccine, 4CMenB (Bexsero(®)), contains recombinant membrane proteins (rMenB) and outer membrane vesicles (OMV) of the New Zealand serogroup B strain. We investigated whether reducing the OMV and/or protein content influences 4CMenB immunogenicity and reactogenicity in healthy two...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.4161/hv.29218

    authors： Esposito S,Prymula R,Zuccotti GV,Xie F,Barone M,Dull PM,Toneatto D

    更新日期：2014-01-01 00:00:00

  • Are children's vitamin D levels and BMI associated with antibody titers produced in response to 2014-2015 influenza vaccine?

    abstract：BACKGROUND:Vitamin D is an immunomodulating hormone, which has been associated with susceptibility to infectious diseases. METHODS:Serum vitamin D levels in 135 children ages 3-17 y were measured at baseline and hemagglutinin influenza antibody titers were measured pre- and 21 d post influenza vaccination with live at...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1299837

    authors： Lin CJ,Martin JM,Cole KS,Zimmerman RK,Susick M,Moehling KK,Levine MZ,Spencer S,Flannery B,Nowalk MP

    更新日期：2017-07-03 00:00:00

  • Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic.

    abstract：:A novel coronavirus (2019-nCov) emerged in China, at the end of December 2019 which posed an International Public Health Emergency, and later declared as a global pandemic by the World Health Organization (WHO). The International Committee on Taxonomy of Viruses (ICTV) named it SARS-CoV-2 (Severe Acute Respiratory Syn...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1824497

    authors： Siddique R,Bai Q,Shereen MA,Nabi G,Han G,Rashid F,Ahmed S,Benzhanova A,Xue M,Khan S

    更新日期：2020-10-16 00:00:00

  • Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.

    abstract：:The aim of this Phase IIIb, open-label, randomized study was to demonstrate the non-inferiority of immune responses and to assess the safety of a purified chick-embryo cell rabies vaccine (PCECV) in healthy Chinese children (6 to 17 years) and older adults (≥51 years) following 2 alternative intramuscular (IM) simulat...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/21645515.2014.994460

    authors： Li R,Li Y,Wen S,Wen H,Nong Y,Mo Z,Xie F,Pellegrini M

    更新日期：2015-01-01 00:00:00

  • Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).

    abstract：:MENK, a penta-peptide is considered as being involved in the regulatory feedback loop between the immune and neuroendocrine systems, with marked modulation of various functions of human immune cells. The aim of the present work was to investigate change of lymphocyte subpopulations in peripheral blood of 50 cancer pat...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.28804

    authors： Wang Q,Gao X,Yuan Z,Wang Z,Meng Y,Cao Y,Plotnikoff NP,Griffin N,Shan F

    更新日期：2014-01-01 00:00:00

  • Premature B-cell senescence as a consequence of chronic immune activation.

    abstract：:Similar features between the immune system of healthy elderly people and of younger individuals subjected to conditions of chronic immune activation are progressively being observed. This is raising the hypothesis that chronic immune activation may cause the premature aging of the immune system. Here we dissect this t...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.28698

    authors： Palma P,Rinaldi S,Cotugno N,Santilli V,Pahwa S,Rossi P,Cagigi A

    更新日期：2014-01-01 00:00:00

  • Recent developments in clinical trial designs for HIV vaccine research.

    abstract：:HIV vaccine strategies are expected to be a crucial component for controlling the HIV epidemic. Despite the large spectrum of potential candidate vaccines for both prophylactic and therapeutic use, the overall development process of an efficacious HIV vaccine strategy is lengthy. The design of clinical trials and the ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2015.1011974

    authors： Richert L,Lhomme E,Fagard C,Lévy Y,Chêne G,Thiébaut R

    更新日期：2015-01-01 00:00:00

  • Mandatory influenza vaccination programs for health care personnel in NACHRI-associated children's hospitals vs. non-children's hospitals.

    abstract：:We conducted a national study of children's hospitals and neighboring general medical-surgical hospitals to examine their employee vaccination policies. Survey questions addressed health care personnel (HCP) influenza vaccination policies for the 2009-2010 (seasonal, H1N1) and 2010-2011 (H1N1 + seasonal = combined) in...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.19613

    authors： Danziger P,Davis MM

    更新日期：2012-06-01 00:00:00

  • Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries.

    abstract：:Novel coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus, which belongs to the genus Coronaviridae with its high mutation rate. From the current perspective, we discuss the current status of COVID-19, new challenges, and potential interventions to control the pandemic in developing counties such as ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1766939

    authors： Anjum FR,Anam S,Rahman SU

    更新日期：2020-10-02 00:00:00

  • What is the cost of delivering routine vaccinations at GP practices in England? A comparative time-driven activity-based costing analysis.

    abstract：:Background: The expansion of available vaccines in recent years has increased the overall costs of the vaccine program and put pressure on providers responsible for vaccination. In England in 2016-17, GP practices responsible for vaccinating their local population were paid £227 million. However, the costs to general ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2019.1619403

    authors： Crocker-Buque T,Mohan K,Ramsay M,Edelstein M,Mounier-Jack S

    更新日期：2019-01-01 00:00:00

  • Rotavirus genotypes in Malaysia and universal rotavirus vaccination.

    abstract：:Group A rotavirus (RV-A) genotypes isolated in Malaysia was studied to estimate the effectiveness of a universal RV-A vaccination in Malaysia. A simple mathematical model was used, with input from a two-year, two-center, prospective study on hospitalization of RV-A gastroenteritis (RVGE) in young children, published d...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.21577

    authors： Lee WS,Lim BT,Chai PF,Kirkwood CD,Lee JK

    更新日期：2012-10-01 00:00:00

  • Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.

    abstract：:Neisseria meningitidis or meningococcus is divided into 12 distinct serogroups of which A, B, C, W, X, and Y are medically most important and cause health problems in different parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. Globally, serogroup A has be...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1051276

    authors： Bröker M,Emonet S,Fazio C,Jacobsson S,Koliou M,Kuusi M,Pace D,Paragi M,Pysik A,Simões MJ,Skoczynska A,Stefanelli P,Toropainen M,Taha MK,Tzanakaki G

    更新日期：2015-01-01 00:00:00

  • Race, ethnicity and income as factors for HPV vaccine acceptance and use.

    abstract：:If distributed equitably, Human Papillomavirus (HPV) vaccines have the potential to reduce racial disparities in HPV-related diseases and cervical cancers. However, current trends in the US indicate low uptake among all adolescents, with persistent disparities among minority and low-income adolescents despite largely ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.24422

    authors： Jeudin P,Liveright E,del Carmen MG,Perkins RB

    更新日期：2013-07-01 00:00:00

  • A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults.

    abstract：:Neisseria meningitidis serogroup B (MnB) is a significant cause of invasive meningococcal disease, but no broadly protective vaccine is yet approved. We assessed the safety and immunogenicity of a bivalent MnB vaccine composed of lipidated subfamily A and B variants of recombinant LP2086 (rLP2086, also known as factor...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/hv.19983

    authors： Sheldon EA,Schwartz H,Jiang Q,Giardina PC,Perez JL

    更新日期：2012-07-01 00:00:00

  • ASVAC2019: 7th Asian Vaccine Conference.

    abstract：:The 7th Asian Vaccine Conference (ASVAC 2019) was held in Yangon, Myanmar from 13 to 15, September 2019. It brought together stakeholders in the field of vaccination to address challenges and issues relevant to clinical practice and immunization programs in the region. The conference themed "Immunization: sustaining h...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2019.1695460

    authors： Linn K,Bravo L,Goh DYT,Nelson EAS

    更新日期：2020-07-02 00:00:00

  • Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

    abstract：BACKGROUND:The study was aimed at comparative evaluation of seasonal influenza vaccine RIBSP versus commercial vaccine VAXIGRIP® for immunogenicity and safety in the course of clinical trial phase II on healthy subjects up to 60 years. METHODS:The trial involved 150 subjects in randomized 2:1 groups that received eith...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2019.1705691

    authors： Sarsenbayeva G,Issagulov T,Kassenov M,Abitay R,Orynbayev M,Stukova M,Pisareva M,Davlyatshin T,Lespek K,Khairullin B

    更新日期：2020-08-02 00:00:00

  • Allergen-specific IgG as a mediator of allergy inhibition: Lessons from mother to child.

    abstract：:Allergen-specific IgG produced by immune mothers is associated with less predisposition to allergy development in their children. This finding has been described by several groups over the last few decades, but the mechanisms by which maternal IgG can inhibit allergy development are still not fully understood. With th...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1244592

    authors： Victor JR

    更新日期：2017-03-04 00:00:00

  • Factors contributing to the immunogenicity of meningococcal conjugate vaccines.

    abstract：:Various glycoprotein conjugate vaccines have been developed for the prevention of invasive meningococcal disease, having significant advantages over pure polysaccharide vaccines. One of the most important features of the conjugate vaccines is the induction of a T-cell dependent immune response, which enables both the ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1153206

    authors： Bröker M,Berti F,Costantino P

    更新日期：2016-07-02 00:00:00